BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2734758)

  • 1. [Hypercalcemia in malignant diseases. Physiopathology and treatment].
    Aasarød K; Lamvik J
    Tidsskr Nor Laegeforen; 1989 Apr; 109(12):1293-6. PubMed ID: 2734758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and management of severe hypercalcemia.
    Nussbaum SR
    Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypercalcemia of tumoral origin with two diphosphonates].
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1822-4. PubMed ID: 6792698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medical treatment of malignant hypercalcemia].
    Eto S; Nakano Y; Okada Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-induced hypercalcemia.
    Lumachi F; Brunello A; Roma A; Basso U
    Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
    Kovacs CS; MacDonald SM; Chik CL; Bruera E
    J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of malignancy: pathophysiology and implications for treatment.
    Theriault RL
    Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to treat tumor-induced hypercalcemia].
    Body JJ
    Rev Prat; 2003 Dec; 53(19):2128-35. PubMed ID: 15008469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignancy-associated hypercalcemia].
    Oura S
    Nihon Rinsho; 2003 Jun; 61(6):1006-9. PubMed ID: 12806951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in the pathogenesis and treatment of neoplastic hypercalcemia].
    Body JJ; Borkowski A
    Rev Med Brux; 1985 Feb; 6(2):81-4. PubMed ID: 3157210
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia].
    Delmas PD; Charhon SA; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018
    [No Abstract]   [Full Text] [Related]  

  • 15. [New development in bisphosphonate treatment. Treatment with bisphosphonates for cancer-induced bone disease].
    Abe M
    Clin Calcium; 2009 Jan; 19(1):55-62. PubMed ID: 19122265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of malignancy associated hypercalcemia].
    Tai N; Inoue D
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bisphosphonates in the treatment of multiple myeloma].
    Stajszczyk M
    Przegl Lek; 2002; 59(1):37-42. PubMed ID: 12108045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF
    Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinosarcoma 256/B in thyroparathyroidectomized rats.
    Kozak S; Rizzoli R; Trechsel U; Fleisch H
    Cancer Res; 1987 Dec; 47(23):6193-7. PubMed ID: 3677071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.